Accelerate Diagnostics, INC Form 4 insider transactions

David Patience, CFO of Accelerate Diagnostics, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Larry Michael Mertz, Chief Technology Officer of Accelerate Diagnostics, sold shares to cover tax obligations following the vesting of restricted stock units.

Larry Michael Mertz, Chief Technology Officer of Accelerate Diagnostics, sold shares to cover tax withholding obligations related to vesting restricted stock units.

CEO Jack Phillips of Accelerate Diagnostics reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

David Patience, CFO of Accelerate Diagnostics, was granted 37,468 restricted stock units (RSUs) on March 5, 2024, which will vest on April 9, 2024.

Larry Michael Mertz, Chief Technology Officer of Accelerate Diagnostics, Inc., was granted 40,633 restricted stock units (RSUs) on March 5, 2024, which vest on April 9, 2024.

CEO Jack Phillips of Accelerate Diagnostics, Inc. was granted 119,856 restricted stock units (RSUs) on March 5, 2024, according to a recent SEC Form 4 filing.

David Patience, CFO of Accelerate Diagnostics, reports the vesting and sale of restricted stock units to cover tax obligations.